John David Finley, CEO, CFO, Director at PALISADE BIO, INC. (PALI), bought 15,000 shares at $0.66 ($10K) on 2023-09-13, disclosed to the SEC on 2023-09-14.
Open-market purchase of $10k PALI by CEO, CFO, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| PALI | BUY | 2024-05-28 | $5K | — | Filing → |
| PALI | BUY | 2024-02-07 | $5K | — | Filing → |
| PALI | BUY | 2024-02-01 | $6K | — | Filing → |